Gan&Lee
Gan&Lee is a high-tech biopharmaceutical enterprise integrating research
Gan & Lee Pharmaceutical Co., Ltd. was established in 1998, is a high-tech biopharmaceutical enterprise integrating research, development, production and sales. The company is a leading company at home and abroad in the development, research and production of biosynthetic human insulin and its analogs, and is a professional company focusing on biosynthetic human insulin analogs.
Innovative Drug Developer Rezu Bio Raised CNY 10 Mn in Series Pre-A
Ganli pharmaceutical won the bid for centralized procurement of insulin glargine injection
Special national collection of insulin: Ganli pharmaceutical Ganjing and asparagus insulin all reported the lowest prices: 48.71 yuan and 19.98 yuan
Robin Li: Baidu has become the world's largest automated driving service provider.
China's First Modified New Drug of Docetaxel Successfully Went to the US
Feb 19, 2025 10:41 AM
During the 14th Five Year Plan period, China will restore 230 million mu of degraded grassland
Pharmaceutical and biological stocks fell sharply in early trading